⌘K

Home/Filings/4/0000899243-22-019219

4//SEC Filing

FRATTAROLI JOSEPH 4

Accession 0000899243-22-019219

CIK 0001750149other

View on SEC.gov Company Profile

Filed

May 22, 8:00 PM ET

Accepted

May 23, 4:54 PM ET

Size

4.4 KB

Accession

0000899243-22-019219

Insider Transaction Report

Form 4

Period: 2022-05-19

Inhibikase Therapeutics, Inc.IKT

FRATTAROLI JOSEPH

Chief Financial Officer

Transactions

Purchase
Common Stock
2022-05-19$0.64/sh+3,948$2,543→ 48,091 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Inhibikase Therapeutics, Inc.

CIK 0001750149

Entity typeother

Related Parties

1

filerCIK 0001272668

Filing Metadata

Form type: 4
Filed: May 22, 8:00 PM ET
Accepted: May 23, 4:54 PM ET
Size: 4.4 KB

View on SEC.gov